Day: September 7, 2021

Gosselies, Belgium, 7 September, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, wishes to respond to a recent press release issued by Hybrigenics (Euronext Paris – ALHYG) following very preliminary contacts made at the initiative of Hybrigenics to examine the combination of certain activities within Bone Therapeutics. Similar to other strategic opportunities that are presented to Bone Therapeutics from time to time, the opportunity for starting discussions with Hybrigenics will be carefully evaluated by the board of directors of Bone Therapeutics, taking into account the interests of its shareholders and other stakeholders. Further announcements will be made in due course, if and when circumstances so allow or require.About...

MARSEILLE, France, Sept. 07, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Wednesday, September 15, 2021, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first half of 2021. Participating in the call will be Innate’s Chief Executive Officer Mondher Mahjoubi, MD, Chief Medical Officer Joyson Karakunnel, MD, MSc, FACP, and Chief Financial Officer Frédéric Lombard, MBA. Details for the Virtual Event The live webcast will be available at the following link: https://edge.media-server.com/mmc/p/bi2jkpjr Participants may also join via telephone to ask questions by registering in advance of the event at http://emea.directeventreg.com/registration/3774818. Upon registration, participants...

Marseille, France, Sept. 07, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Wednesday, September 15, 2021, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first half of 2021.   Participating in the call will be Innate’s Chief Executive Officer Mondher Mahjoubi, MD, Chief Medical Officer Joyson Karakunnel, MD, MSc, FACP, and Chief Financial Officer Frédéric Lombard, MBA.   Details for the Virtual Event   The live webcast will be available at the following link: https://edge.media-server.com/mmc/p/bi2jkpjr   Participants may also join via telephone to ask questions by registering in advance of the event at http://emea.directeventreg.com/registration/3774818. Upon registration, participants...